Heranova – Lifesciences
Heranova Lifesciences Announces 2025 Conference Schedule
Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong
Heranova™ Launches Early Access Program for HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test
Heranova™ Appoints Dr. Marcel van Duin as Chief Scientific Officer
Heranova™ Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women’s Health
/ / /
SEE ALL RELEASES